ChemoMetec AS (OCSE:CHEMM) LT-Debt-to-Total-Asset : 0.01 (As of Dec. 2024)

View and export this data going back to 2006. Start your Free Trial

What is ChemoMetec AS LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. ChemoMetec AS's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.01.

ChemoMetec AS's long-term debt to total assets ratio increased from Dec. 2023 (0.00) to Dec. 2024 (0.01). It may suggest that ChemoMetec AS is progressively becoming more dependent on debt to grow their business.

ChemoMetec AS LT-Debt-to-Total-Asset Historical Data

The historical data trend for ChemoMetec AS's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec AS LT-Debt-to-Total-Asset Chart

ChemoMetec AS Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

ChemoMetec AS Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	0.01	-	-	0.01

ChemoMetec AS LT-Debt-to-Total-Asset Calculation

ChemoMetec AS's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (A: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2024 )	/	Total Assets (A: Jun. 2024 )
	=	0.974	/	676.673
	=	0.00

ChemoMetec AS's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	4.659	/	730.218
	=	0.01

ChemoMetec AS (OCSE:CHEMM) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

ChemoMetec AS LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of ChemoMetec AS's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

ChemoMetec AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (OCSE:CHEMM) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

CHEMMc:UK 0DZ0:UK CHY:Germany

Address

Gydevang 43, Allerod, DNK, 3450

Website

https://www.chemometec.com

ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.

ChemoMetec AS Headlines

No Headlines